{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:38:28Z","timestamp":1791117508150,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PHRC-N, French Ministry of Health","award":["PHRC-18-0127"],"award-info":[{"award-number":["PHRC-18-0127"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients who are admitted to the intensive care unit (ICU) for severe acute exacerbations of chronic obstructive pulmonary disease (COPD) have poor outcomes. Although international clinical practice guidelines cautiously recommend the routine use of systemic corticosteroids for COPD exacerbations, data are scarce and inconclusive regarding their benefit for most severe patients who require mechanical ventilation in the ICU. Furthermore, corticosteroids may be associated with an increased risk of infection, ICU-acquired limb weakness, and metabolic disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and analysis<\/jats:title>\n                <jats:p>This study is an investigator-initiated, multicentre, randomized, placebo-controlled, double-blind trial comparing systemic corticosteroids to placebo during severe acute exacerbations of COPD in patients who require mechanical ventilation in French ICUs. A total of 440 patients will be randomized 1:1 to methylprednisolone (1\u00a0mg\/kg) or placebo for 5\u00a0days, and stratified according to initial mechanical ventilation (non-invasive or invasive), pneumonia as triggering factor, and recent use of systemic corticosteroids (&lt;\u200948\u00a0h). The primary outcome is the number of ventilator-free days at day 28, defined as the number of days alive and without mechanical invasive and\/or non-invasive ventilation between randomization and day 28. Secondary outcomes include non-invasive ventilation (NIV) failure rate, duration of mechanical ventilation (invasive and\/or NIV), circulatory support (vasopressor), outcomes related to corticosteroid adverse events (severe hyperglycaemia, gastrointestinal bleeding, uncontrolled arterial hypertension, ICU-acquired weakness, ICU-acquired infections, and delirium), lengths of ICU and hospital stay, ICU and hospital mortality, day 28 and day 90 mortality, number of new exacerbation(s)\/hospitalization(s) between hospital discharge and day 90, and dyspnoea and comfort at randomization, ICU discharge, and day 90. Subgroup analyses for the primary outcome are planned according to stratification criteria at randomization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07229-9","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:19:24Z","timestamp":1679865564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-8274","authenticated-orcid":false,"given":"Alexis","family":"Ferr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud W.","family":"Thille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mekontso-Dessap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Similowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Legriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aegerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Demoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The R\u00e9seau Europ\u00e9en de Recherche en Ventilation Artificielle (REVA) research network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,26]]},"reference":[{"key":"7229_CR1","unstructured":"World Health Organization. Chronic obstructive pulmonary disease (COPD). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd). Accessed 24 Feb 2023."},{"issue":"Suppl 2","key":"7229_CR2","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-208209","volume":"71","author":"AC Davidson","year":"2016","unstructured":"Davidson AC, Banham S, Elliott M, Kennedy D, Gelder C, Glossop A, et al. BTS\/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016;71(Suppl 2):ii1-35.","journal-title":"Thorax"},{"key":"7229_CR3","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1097\/CCM.0b013e31828a2bd8","volume":"41","author":"M Dres","year":"2013","unstructured":"Dres M, Tran TC, Aegerter P, Rabbat A, Guidet B, Huchon G, et al. Influence of ICU case-volume on the management and hospital outcomes of acute exacerbations of chronic obstructive pulmonary disease. Crit Care Med. 2013;41:1884\u201392.","journal-title":"Crit Care Med"},{"key":"7229_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/0003-4819-92-6-753","volume":"92","author":"RK Albert","year":"1980","unstructured":"Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med. 1980;92:753\u20138.","journal-title":"Ann Intern Med"},{"key":"7229_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1164\/ajrccm.154.2.8756814","volume":"154","author":"WH Thompson","year":"1996","unstructured":"Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med. 1996;154:407\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"7229_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","volume":"354","author":"L Davies","year":"1999","unstructured":"Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999;354:456\u201360.","journal-title":"Lancet"},{"key":"7229_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJM199906243402502","volume":"340","author":"DE Niewoehner","year":"1999","unstructured":"Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med. 1999;340:1941\u20137.","journal-title":"N Engl J Med"},{"key":"7229_CR8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1164\/ajrccm.165.5.2109093","volume":"165","author":"F Maltais","year":"2002","unstructured":"Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2002;165:698\u2013703.","journal-title":"Am J Respir Crit Care Med"},{"key":"7229_CR9","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1056\/NEJMoa023161","volume":"348","author":"SD Aaron","year":"2003","unstructured":"Aaron SD, Vandemheen KL, Hebert P, Dales R, Stiell IG, Ahuja J, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003;348:2618\u201325.","journal-title":"N Engl J Med"},{"key":"7229_CR10","doi-asserted-by":"publisher","first-page":"1700214","DOI":"10.1183\/13993003.00214-2017","volume":"49","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49:1700214.","journal-title":"Eur Respir J"},{"key":"7229_CR11","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1001\/archinternmed.2011.530","volume":"171","author":"I Al\u00eda","year":"2011","unstructured":"Al\u00eda I, de la Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med. 2011;171:1939\u201346.","journal-title":"Arch Intern Med"},{"key":"7229_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1183\/09031936.00002913","volume":"43","author":"F Abroug","year":"2014","unstructured":"Abroug F, Ouanes-Besbes L, Fkih-Hassen M, Ouanes I, Ayed S, Dachraoui F, et al. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J. 2014;43:717\u201324.","journal-title":"Eur Respir J"},{"key":"7229_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.rmr.2017.03.034","volume":"34","author":"S Jouneau","year":"2017","unstructured":"Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, et al. Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Societe de pneumologie de langue francaise (summary). Rev Mal Respir. 2017;34:282\u2013322.","journal-title":"Rev Mal Respir"},{"key":"7229_CR14","doi-asserted-by":"publisher","first-page":"1602426","DOI":"10.1183\/13993003.02426-2016","volume":"50","author":"B Rochwerg","year":"2017","unstructured":"Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50:1602426.","journal-title":"Eur Respir J"},{"key":"7229_CR15","doi-asserted-by":"crossref","unstructured":"Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev.\u00a02004;(1):CD004104.","DOI":"10.1002\/14651858.CD004104.pub3"},{"key":"7229_CR16","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825\u201373.","journal-title":"Crit Care Med"},{"key":"7229_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1183\/09031936.00010206","volume":"29","author":"JM Boles","year":"2007","unstructured":"Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29:1033\u201356.","journal-title":"Eur Respir J"},{"key":"7229_CR18","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, ARDS Definition Task Force, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526\u201333.","journal-title":"JAMA"},{"key":"7229_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.accpm.2017.09.001","volume":"36","author":"H Quintard","year":"2017","unstructured":"Quintard H, l\u2019Her E, Pottecher J, Adnet F, Constantin JM, De Jong A, et al. Intubation and extubation of the ICU patient. Anaesth Crit Care Pain Med. 2017;36:327\u201341.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"7229_CR20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1097\/CCM.0b013e3182282a5a","volume":"39","author":"AW Thille","year":"2011","unstructured":"Thille AW, Harrois A, Schortgen F, Brun-Buisson C, Brochard L. Outcomes of extubation failure in medical intensive care unit patients. Crit Care Med. 2011;39:2612\u20138.","journal-title":"Crit Care Med"},{"key":"7229_CR21","unstructured":"European Medicines Agency. Guidelines on adjustment for baseline covariates in clinical trials. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/03\/WC500184923.pdf. Accessed 24 Feb 2023."},{"key":"7229_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJM199509283331301","volume":"333","author":"L Brochard","year":"1995","unstructured":"Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333:817\u201322.","journal-title":"N Engl J Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07229-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07229-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07229-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:19:31Z","timestamp":1679865571000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07229-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,26]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7229"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07229-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,26]]},"assertion":[{"value":"27 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by an ethics committee (Comit\u00e9 de Protection des Personnes Ouest VI, CPP Ouest 6 \u2013 CPP 1194 ME1) and patients will be included after informed consent, next of kin consent, or an emergency procedure with patient deferred consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"AF reports honoraria by Fisher & Paykel for a lecture during SFMU Congress 2022, outside the submitted work.AWT reports financial support (payment for lectures and travel expenses coverage to attend scientific meetings) by Fisher & Paykel, GE Healthcare, and Philips, all outside the submitted work.AMD reports grants from Fischer Paykel, and personal fees from Air Liquide and Addmedica, all outside the submitted work.TS reports personal fees from ADEP assistance, AstraZeneca France, Boehringer Ingelheim France, Chiesi France, Lungpacer Inc, Novartis France, and Vitalaire (over the past 3\u00a0years), all outside the submitted work.PA and SL declare that they have no competing interests.AD reports grants from the French Ministry of Health, Assistance publique \u2013 H\u00f4pitaux de Paris, Lungpacer, Respinor; consulting fees from Respinor, Lungpace, Lowenstein, Tribunal administratif de Cergy, Liberate Medical; payment or honoraria for lectures, presentations from Fisher & Paykel, Baxter, Getinge, Astra, Agence Europ\u00e9enne Informatique, Mindray; and support for attending meetings and\/or travel from Lungpacer, outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"231"}}